Viewing Study NCT06364956


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2025-12-29 @ 10:42 PM
Study NCT ID: NCT06364956
Status: RECRUITING
Last Update Posted: 2025-08-11
First Post: 2024-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module